What is FutureCure Health's focus?

FutureCure Health focuses on super-speciality care, particularly in diagnosing and treating vertigo and dizziness through its subsidiary NeuroEquilibrium.

How much funding did FutureCure Health receive?

FutureCure Health recently raised Rs 104 crore ($11.5 million) in a funding round led by Carnelian Asset Management.

What is NeuroEquilibrium's approach to vertigo?

NeuroEquilibrium identifies the root cause of vertigo, whether from the inner ear, brain, or balance pathways, enabling targeted treatment using advanced diagnostics and technology.

Home / Business and Economy / FutureCure Raises $11.5M for Vertigo Care Expansion

FutureCure Raises $11.5M for Vertigo Care Expansion

6 Jan

•

Summary

FutureCure Health secured Rs 104 crore funding led by Carnelian Asset Management.
The company aims to expand access to vertigo diagnosis and treatment.
NeuroEquilibrium, a subsidiary, uses tech to bridge specialist doctor shortages.

FutureCure Raises $11.5M for Vertigo Care Expansion

FutureCure Health, a healthcare technology firm specializing in super-speciality care, has successfully secured Rs 104 crore ($11.5 million) in a recent funding round. The investment was spearheaded by Carnelian Asset Management LLP, with contributions from other investors, bolstering the company's mission to enhance healthcare accessibility.

These newly acquired funds are earmarked for significant expansion, particularly in making vertigo diagnosis and treatment more widely available. FutureCure operates NeuroEquilibrium, a wholly-owned subsidiary that runs specialized clinics for dizziness and vertigo. This chain focuses on identifying the root causes of vertigo, employing advanced diagnostics and cloud-based remote platforms to deliver precise care.

The company's innovative approach tackles a global shortage of neuro-otology specialists. By integrating deep-tech, FutureCure aims to scale precision medicine beyond urban centers and expand into areas like migraine and diabetes management, ultimately democratizing specialized healthcare.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FutureCure Raises $11.5M for Vertigo Care Expansion

6 Jan

•

Summary

FutureCure Health secured Rs 104 crore funding led by Carnelian Asset Management.
The company aims to expand access to vertigo diagnosis and treatment.
NeuroEquilibrium, a subsidiary, uses tech to bridge specialist doctor shortages.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.